Refine
Is part of the Bibliography
- yes (211)
Year of publication
- 2011 (211) (remove)
Document Type
- Journal article (211) (remove)
Language
- English (211) (remove)
Keywords
- Medizin (15)
- Expression (9)
- Activation (8)
- Cancer (6)
- Mice (5)
- Therapy (5)
- Apoptosis (4)
- In-vivo (4)
- apoptosis (4)
- Biologie (3)
- Dendritische Zelle (3)
- Gene-expression (3)
- Model (3)
- Nude-mice (3)
- Prevalence (3)
- Virologie (3)
- fNIRS (3)
- mouse models (3)
- Agent (2)
- Antibody (2)
- B chromosomes (2)
- Biology (2)
- Brain (2)
- Breast-cancer (2)
- Breast-tumors (2)
- CD95 (2)
- Children (2)
- DNA (2)
- DNA methylation (2)
- Depression (2)
- Disease (2)
- Emotional processing (2)
- Evolution (2)
- Fusion proteins (2)
- GLV-1H68 (2)
- Gene (2)
- Genes (2)
- Growth (2)
- HIV (2)
- Heart failure (2)
- Human brain (2)
- IN-VIVO (2)
- Inflammation (2)
- Inhibitor (2)
- Ketogenic diet (2)
- Krebs (2)
- Krebs <Medizin> (2)
- Listeria monocytogenes (2)
- Lung-cancer (2)
- Maus (2)
- Mechanisms (2)
- Medicine (2)
- Mortality (2)
- Mouse-brain (2)
- NFkB (2)
- PALM (2)
- Pathway (2)
- Physik (2)
- Promoter (2)
- Protein (2)
- Psychologie (2)
- Pädiatrie (2)
- RNA (2)
- Regression (2)
- Rheumatologie (2)
- Risk (2)
- Staphylococcus aureus (2)
- Stimuli (2)
- Streptomyces axinellae (2)
- TNF (2)
- TRAIL (2)
- Transcription (2)
- Transporter (2)
- Tumor-necrosis-factor (2)
- activation (2)
- anti-trypanosomal (2)
- bacteria (2)
- breast cancer (2)
- cancer (2)
- children (2)
- cytoskeleton (2)
- dSTORM (2)
- diagnosis (2)
- emotional regulation (2)
- fluorescent proteins (2)
- head (2)
- identification (2)
- marine sponge (2)
- multiple myeloma (2)
- neurons (2)
- photoswitchable organic fluorophores (2)
- protease inhibition (2)
- protein (2)
- super-resolution (2)
- tetromycin (2)
- (13)C (1)
- 26S RDNA Data (1)
- 316L stainless-steel (1)
- 5-HT (1)
- 5-HT transporter (1)
- 5-HT1A (1)
- 5-HT2C (1)
- 65-kda isoform (1)
- A chromosomes (1)
- AD5 mutation (1)
- ADHD (1)
- AFLP (1)
- AML (1)
- Acute Myocardial Infarction (1)
- Acute tryptophan depletion (1)
- Adenocarcinomas (1)
- Adult head (1)
- African Trypanosomes (1)
- African-americans (1)
- Agalsidase beta therapy (1)
- Age (1)
- Allelic loss (1)
- Alpha galactosidase (1)
- Alpha-dependent apoptosis (1)
- Alpha-galactosidase (1)
- Alzheimer disease (1)
- Amazonian forest (1)
- Ameisen (1)
- Amino acids (1)
- Amplification (1)
- Ankyrin (1)
- Ant-following birds (1)
- Anterior inferotemporal cortex (1)
- Antigen 4 (1)
- Anxiety (1)
- Anxiety-like behavior (1)
- Arabidopsis thaliana (1)
- Arterial water (1)
- Aspartate Aminotransferases (1)
- Assemblages (1)
- Attention (1)
- Attention-deficit/hyperactivity disorder (1)
- Auditory targets (1)
- Autoimmune-Diseases (1)
- BRCA1 (1)
- BRM (1)
- Bacillus-subtilis (1)
- Bacterial conjugation (1)
- Barcodes (1)
- Barrett-Ösophagus (1)
- Base composition (1)
- Beer-lambert law (1)
- Behavior (1)
- Beta-glucocerebrosidase (1)
- Biased gene conversion (1)
- Biene (1)
- Biokinetics (1)
- Biological identifications (1)
- Biomarkers (1)
- Bipolar disorder (1)
- Blattschneiderameisen (1)
- Blood-brain barrier (1)
- Blood-brain-barrier (1)
- Body weight (1)
- Bone morphogenetic protein-2 (1)
- Botanik (1)
- Brahma (1)
- Brownsche Bewegung (1)
- Brucei (1)
- C-IAP1 (1)
- C-MYC (1)
- C-elegans (1)
- CD105 antigen (1)
- CD34 antigen (1)
- CD9 (1)
- CEF (1)
- CIAP1 (1)
- CIN (1)
- COX-2 (1)
- CYR61 (1)
- Candida albicans (1)
- Capsaicin receptor (1)
- Carcinoma (1)
- Carcinomatosis (1)
- Cardiac resynchronization therapy defibrillator (1)
- Cardiovascular Magnetic Resonance (1)
- Cardiovascular hospitalizations (1)
- Caspase-8 activation (1)
- Cataglyphis-fortis (1)
- Cell Motility (1)
- Cell permeability (1)
- Cell surface (1)
- Cell-line (1)
- Central complex (1)
- Channelrhodopsin-2 (1)
- Checkpoints (1)
- Chemie (1)
- Chemosensory neurons (1)
- Chemotaxis (1)
- Chernobyl (1)
- Childhood (1)
- Childhood medulloblastoma (1)
- China (1)
- Chinese family (1)
- Chinese politics (1)
- Chlamydia pneumoniae (1)
- Chlamydiales (1)
- Chromatin-remodeling complexes (1)
- Chromosomal instability (1)
- Chronic Kidney-disease (1)
- Chronic kidney-disease (1)
- Cisplatin (1)
- Clinical manifestations (1)
- Clinical proteomics (1)
- Clinical-trials (1)
- Co (1)
- CoPt (1)
- Coefficient (1)
- Coexpression (1)
- Cognitive representation (1)
- Cold (1)
- Coleoptera (1)
- Colonial volvocales chlorophyta (1)
- Comorbidities (1)
- Comorbidity survey replication (1)
- Complex (1)
- Components (1)
- Condensed matter (1)
- Confucianism; East Asia; Traditional Values (1)
- Conservation (1)
- Creatine Kinase (1)
- Crop seed (1)
- CrossQuery (1)
- Cumulative incidence function (1)
- Cyclic nucleotides (1)
- Cytologie (1)
- DNA barcodes (1)
- DNA hypermethylation (1)
- DNA recombination (1)
- DSM-IV disorders (1)
- Damage (1)
- Dasycladales chlorophyta (1)
- Dauer formation (1)
- Defined burkitts lymphoma (1)
- Deletion (1)
- Deliberate practice (1)
- Demyelinating peripheral neuropathy (1)
- Dendritic Cells (1)
- Dendritic cell tumor (1)
- Desert ant navigation (1)
- Desmoplakin (1)
- Deterioration (1)
- Deutschland (1)
- Diabetic-nephropathy (1)
- Diagnosis (1)
- Diagnostic radiopharmaceuticals (1)
- Diarrhea (1)
- Diastocic Dysfunction (1)
- Differentiation (1)
- Discovery (1)
- Disease progression (1)
- Disease-modifying therapies (1)
- Disorders (1)
- Distinct (1)
- Division (1)
- Dopamine (1)
- Dorylinae (1)
- Dosimetry (1)
- Down-regulation (1)
- Drosophila Antennal Lobe (1)
- Drug development (1)
- ERI (1)
- Early-onset (1)
- Edema formation (1)
- Effective dose (1)
- Elektronisches Publizieren (1)
- Embryo (1)
- England (1)
- Enterica serovar typhimurium (1)
- Enzyme immunoassay (1)
- Enzyme replacement therapy (1)
- Epilepsy (1)
- Eplerenone (1)
- Escherichia coli (1)
- Escherichia-coli K-12 (1)
- Excision (1)
- Exons (1)
- Experimental intracerebral hemorrhage (1)
- Experimental stroke (1)
- Expert chess players (1)
- Expresses genes (1)
- F-19 MRI (1)
- Fabry (1)
- Factor gene PRPF31 (1)
- Factor receptor (1)
- Factor sigma(B) (1)
- Factor-alpha (1)
- Family (1)
- Fanconi Anemia (1)
- Fanconi-Anämie (1)
- Fibroblasts (1)
- Fibromyalgie (1)
- Fische (1)
- Flagellum (1)
- Fluorescence in situ hybridization (1)
- Fluorescence microscopy (1)
- Follow-up (1)
- Formicidae (1)
- FoxP3 Expression (1)
- Framingham (1)
- Ftsz (1)
- Function knowledge (1)
- Functional diversity (1)
- GAG (1)
- GAP (1)
- GC-Content (1)
- GI-101A tumor xenografts (1)
- GRAID (1)
- Gehirn (1)
- Gene-transfer (1)
- General-population (1)
- Genetik (1)
- Genome wide analysis (1)
- Geruch (1)
- Globotriaosylceramide (1)
- Glomerular-filtration-rate (1)
- Glutamate-induced excitotoxicity (1)
- Glutamate-receptor (1)
- Glutamic-acid decarboxylase anxiety (1)
- Gradients (1)
- Gram-positive bacteria (1)
- Grippe (1)
- Growth-factor receptor (1)
- H-1-NMR spectroscopy (1)
- HIV diagnosis and management (1)
- HRTEM (1)
- Habichtskraut (1)
- Habitat fragmentation (1)
- Haemodialysis (1)
- Hautkrebs (1)
- Hazards (1)
- Heart failure with preserved ejection fraction (1)
- Heart failure with reduced ejection fraction (1)
- Heat Hyperalgesia (1)
- Helicobacter pylori (1)
- Hemagglutination inhibition (1)
- Hemodialysis-patients (1)
- Heparan-sulfate (1)
- Hereditary breast cancer (1)
- Hieracium (1)
- High-Frequency Ventilation (1)
- High-jump photographs (1)
- High-resolution (1)
- Higher rates (1)
- Histone deacetylase inhibition (1)
- Home monitoring (1)
- Homebox gene (1)
- Homoarginine (1)
- Honey-bees (1)
- Human Sodium/Iodide symporter (1)
- Human genome (1)
- Human lung-cancer (1)
- Human-immunodeficiency-virus (1)
- Hyperalgesia (1)
- Hyperkalemia (1)
- IMAT (1)
- Ifn-gamma (1)
- Images (1)
- Immune-System (1)
- Immunogenicity (1)
- Immunological Self-Tolerance (1)
- Immunstimulation (1)
- In Situ Nick-End Labeling (1)
- In-Vivo (1)
- In-vitro (1)
- Inactivation (1)
- Induced apoptosis (1)
- Induced senescence (1)
- Infarct Zone (1)
- Infection (1)
- Inhibition (1)
- Insensitivity (1)
- Instability (1)
- Insulin (1)
- Insulin Degrading Enzyme (1)
- Interactive Ventilatory Support (1)
- Interferon-alpha (1)
- Interleukin-6 (1)
- Interleukin-6-Deficient mice (1)
- International Physical Activity Questionnaire (1)
- Internet (1)
- Internet Behaviour (1)
- Invasion genes (1)
- Iron Oxide Nanoparticle (1)
- Iron-oxide (1)
- Iron-uptake (1)
- Jugend (1)
- Juvenile biventricular cardiomyopathy (1)
- K-RAS (1)
- Kappa-B activation (1)
- Kappa-B pathway (1)
- Kenya (1)
- Keuchhusten (1)
- Kinase pathway (1)
- Knock-out mice (1)
- Krebskranker (1)
- Kristallographie (1)
- L-Lactate Dehydrogenase (1)
- LAD (1)
- LIMP-2 (1)
- LINC complex (1)
- Land plants (1)
- Land-use change (1)
- Landschaft (1)
- Landwirtschaft (1)
- Language comprehension (1)
- Larval development (1)
- Latency (1)
- Lebensqualität (1)
- Lesions (1)
- Leukemia Inhibitory Factor (1)
- Level (1)
- Ligand (1)
- Limit (1)
- Lines (1)
- Lipom (1)
- Lipophilicity (1)
- Live cells (1)
- Living cells (1)
- Local governance (1)
- Locked-in syndrome (1)
- Logged forests (1)
- Long-term depression (1)
- Lov domain (1)
- Lung Injury (1)
- MRI (1)
- MRI reporter (1)
- Macaque monkey (1)
- Machine learning (1)
- Madagascar (1)
- Magnetic-resonance (1)
- Magnetic-resonance microscopy (1)
- Maintenance (1)
- Major depression (1)
- Malignant neoplasms (1)
- Mammakarzinom (1)
- Mammalian genomes (1)
- Mammalian target (1)
- Mantle cell lymphoma (1)
- Mass-spectrometry (1)
- Materials science (1)
- Media (1)
- Mediated Inflammatory Hyperalgesia (1)
- Melanoma-cells (1)
- Melophorus-bagoti (1)
- Memory (1)
- Mesoskopisches System (1)
- Messenger-RNA (1)
- Metaanalysis (1)
- MicroRNAs (1)
- Microarray (1)
- Microarray data (1)
- Middle cerebral-artery (1)
- Migräne (1)
- Millisecond-timescale (1)
- Molecular pathogenesis (1)
- Molecular systematics (1)
- Molecular-genetics (1)
- Molecules (1)
- Monte-Carlo-Simulation (1)
- Mood disorders (1)
- Morbidity (1)
- Motion (1)
- Movement (1)
- Multiparameter predictor (1)
- Multiple-Sclerosis (1)
- Mushroom bodies (1)
- Mutations (1)
- Myocardial-Infarction (1)
- Myofibroblast differentiation (1)
- N-Myc (1)
- NA+/I-symporter (1)
- NF-Kappa-B (1)
- NMR (1)
- NPSI (1)
- NPY (1)
- NTP-binding-properties (1)
- Necrosis (1)
- Necrosis-factor-Alpha (1)
- Nematode Caenorhabditis-elegans (1)
- Netzwerk (1)
- Neural basis (1)
- Neural precursor cells (1)
- Neuralgie (1)
- Neuro-blastoma (1)
- Neuroblastoma (1)
- Neurogenic inflammation (1)
- Neuronal plasticity (1)
- Neurons (1)
- Neuropathy (1)
- Neuroprotection (1)
- Neutrophils (1)
- Non-phototrophic bacteria (1)
- Non-reactive Measurement (1)
- Nonpathogenic Escherichia-coli (1)
- Nuclear RDNA (1)
- Nuclear expression (1)
- Oil (1)
- Oncostatin-M-Receptor (1)
- Onset hypertrophic cardiomyopathy (1)
- Optical control (1)
- Ostasien (1)
- Outcome survey (1)
- Outcomes (1)
- Outlier detection (1)
- Own-name (1)
- P53 (1)
- PCI (1)
- PET-1 (1)
- PPGPP (1)
- PRPF31 (1)
- Pain (1)
- Palliativmedizin (1)
- Palmoplantar keratoderma (1)
- Paradoxical heat sensation (1)
- Parataxonomy (1)
- Parietal cortex (1)
- Parkinson disease (1)
- Parkinsons-disease (1)
- Parkinson’s disease (1)
- Partially parallel acquisitions (1)
- Particle physics (1)
- Particles (1)
- Path-integraton (1)
- Pathologic neovascularization (1)
- Pattern classification (1)
- Patterns (1)
- Pentastomiasis (1)
- Perception (1)
- Perfusion (1)
- Peripheral Inflammation (1)
- Pharmacological management (1)
- Pheromone (1)
- Photoactivated localization microscopy (1)
- Photon migration (1)
- Physical Activity (1)
- Physical Sciences (1)
- Physical impairment (1)
- Physical sciences (1)
- Physiological functions (1)
- Plantation forests (1)
- Plants (1)
- Plasma-membrane (1)
- Politik (1)
- Polymorphisms (1)
- Positive-Pressure Respiration (1)
- Potentials (1)
- Predictors (1)
- Preserved Ejection Fraction (1)
- Prfa-mediated virulence (1)
- Probabilities (1)
- Profile distances (1)
- Progenitor cells (1)
- Progression (1)
- Proliferation (1)
- Propagation (1)
- Prosaccade (1)
- Proteins (1)
- Prunus-africana (1)
- Pseudomonas-aeruginosa (1)
- Pt (1)
- QCM (1)
- Quality of life (1)
- Question format (1)
- R factor = 0.027 (1)
- RBCL Gene-sequences (1)
- RIP1 (1)
- RNA sequence analyses (1)
- RNA-SEQ (1)
- RNS (1)
- RP11 (1)
- Radical prostatectomy (1)
- Radiotherapy (1)
- Rain-forest (1)
- Random-Walk (1)
- Randomized controlled trial (1)
- Rat Sensory Neurons (1)
- Rat spinal-cord (1)
- Rat-brain (1)
- Rats (1)
- Real-time (1)
- Receptor (1)
- Receptor ytva (1)
- Recombinant vaccinia (1)
- Recombination directionality factor (1)
- Recurrent neural-networks (1)
- Remote device monitoring (1)
- Repair (1)
- Reporter gene (1)
- Restraint stress (1)
- Retinitis pigmentosa (RP) (1)
- Retinoic acid (1)
- Rheumatoid-Arthritis (1)
- Rochester diabetic neuropathy (1)
- Rodents (1)
- Rural politics (1)
- SP117 mutation (1)
- SUBSP carotovora (1)
- SUN domain protein (1)
- Saccadic eye-movements (1)
- Safety (1)
- Salmonella (1)
- Salmonella-typhimurium (1)
- Sample-sizes (1)
- Scale (1)
- Scattering (1)
- Schizophrenie (1)
- Search Volume Index (1)
- Secondary structure (1)
- Sedentary Behavior (1)
- Seed dispersal (1)
- Sensitivity (1)
- Sentence comprehension (1)
- Serotonin transporter (1)
- Serotonin transporter polymorphism (1)
- Serum autoantibodies (1)
- Sex-Hormones (1)
- Sigma(B)-dependent stress-response (1)
- Signaling complex (1)
- Single-chain TNF (1)
- Skelettmuskel (1)
- Small-fiber neuropathy (1)
- Smooth-muscle-cells (1)
- Social Desirability (1)
- Soft-tissue infection (1)
- Soft-tissue sarcoma (1)
- Sonic hedgehog (1)
- Sox9 (1)
- Soybean seeds (1)
- Species richness (1)
- Spectroscopy fnirs (1)
- Sprouting angiogenesis (1)
- Squalius alburnoides (1)
- Stability (1)
- Stachellose Biene (1)
- Stage renal-disease (1)
- Staphylococcus-aureus (1)
- Step and Shoot IMRT (1)
- Stimulated-emission (1)
- Storage (1)
- Strahlentherapie (1)
- Strain nissle-1917 (1)
- Subdistribution (1)
- Subliminal priming (1)
- Subunit (1)
- Sudden cardiac death (1)
- Sugar-transport (1)
- Suicide vector (1)
- Sun1 (1)
- Super-Resolution Microscopy (1)
- Superparamagnetic Iron Oxide (1)
- Support Vector Machine (1)
- Suppressive Function (1)
- Suppressors EXT1 (1)
- Surrogate endpoints (1)
- Surveillance (1)
- Survival (1)
- Susceptibility (1)
- Switch (1)
- Symptomlinderung (1)
- System (1)
- Systematic search (1)
- Systemic-Lupus-Erythematosus (1)
- T = 174 K (1)
- T cells (1)
- T-lymphocytes (1)
- TGF-beta (1)
- TRAF2 (1)
- TRI-SNRNP (1)
- TRP Channels (1)
- TYPE-1 (1)
- Tansania (1)
- Tanzania (1)
- Targets (1)
- Task (1)
- Task-performance (1)
- Taxonomy (1)
- Temporal areas (1)
- Tests (1)
- Text information (1)
- Thermal Hyperalgesia (1)
- Time (1)
- Time-course (1)
- Time-domain NMR (1)
- Tissue (1)
- Tissues (1)
- Total Physical Activity (1)
- Toxikologie (1)
- Tracking (1)
- Transcription-factor (1)
- Transfer-RNA modification (1)
- Transgenic mice (1)
- Transgenic zebrafish (1)
- Transport (1)
- Treatment (1)
- Triple in situ hybridization (1)
- Trithorax (1)
- Trypanosoma brucei (1)
- Trypanosome (1)
- Typhoid-fever (1)
- Up-regulation (1)
- VASP (1)
- VMAT (1)
- VSG (1)
- Vaccine (1)
- Variants (1)
- Varizellen-Virus (1)
- Vasodilatator-stimuliertes Phosphoprotein (1)
- Vegetative state (1)
- Vergence (1)
- Verhaltenstherapie (1)
- Verification (1)
- Village election (1)
- Viruses (1)
- Virusinfektion (1)
- Voluntary control (1)
- Von-Willebrand-factor (1)
- Wardrobe Malfunction (1)
- White-matter (1)
- Wilms tumor (1)
- X chromosome (1)
- XMCD (1)
- Yersinia-pseudotuberculosis (1)
- Young-patients (1)
- Zelllysat (1)
- Zoologie (1)
- Zytokin-induzierte Killerzellen (1)
- acetylcholine (1)
- adaptive immunity (1)
- adenovirus (1)
- adrenal cortex hormones (1)
- adrenal cortex neoplasms (1)
- advanced stages (1)
- africans (1)
- allodynia (1)
- alloy (1)
- animal behavior (1)
- ant (1)
- antennal lobe (1)
- antibodies (1)
- antidepressive agents (1)
- antigen processing and recognition (1)
- antimicrobial resistance (1)
- antimicrobials (1)
- antiretroviral therapy (1)
- antiretrovirals (1)
- anxiety (1)
- arrow cues (1)
- asexual reproduction (1)
- autoantibodies (1)
- autofluorescence (1)
- basal ganglia (1)
- beta-glucuronidase (1)
- biomechanics (1)
- biopsy (1)
- biosensor (1)
- biosensors (1)
- blast cell lysate (1)
- blast-derived RNA (1)
- blood-plasma (1)
- bone (1)
- cachexia (1)
- cameleon (1)
- campestris PV vesicatoria (1)
- cancer patients (1)
- cell coagulation (1)
- cell cycle (1)
- cell self-assembled monolayers (1)
- cell staining (1)
- cell-cycle dependence (1)
- cervical vertebrae pneumatization (1)
- chemistry (1)
- chronic pain (1)
- cidofovir (1)
- cis-acting sequences (1)
- comparative genomics (1)
- concurrent design facility (1)
- cone-beam ct (1)
- congenital melanocytic nevi (1)
- consesus (1)
- contingent capture (1)
- cue (1)
- cyclic nucleotide signaling (1)
- cyclic-gmp (1)
- cysteine protease (1)
- cytokine-induced killer cells (1)
- cytokines (1)
- cytotoxic T cells (1)
- damage assessment disaster (1)
- data-to-parameter ratio = 23.6. (1)
- dendritic cells (1)
- dendritische Zellen (1)
- depression (1)
- determines pathgenicity (1)
- developmental signaling (1)
- diet (1)
- disaster (1)
- discovery (1)
- disorder (1)
- dna-binding protein (1)
- dominant-negative (1)
- dopamine (1)
- dopaminergics (1)
- down-regulation (1)
- drosophila melanogaster (1)
- drugs (1)
- earthquake (1)
- electrical resistivity imaging (1)
- electroencephalography (1)
- embryos (1)
- emulsions (1)
- energy-transfer (1)
- enhance viral transcription (1)
- env leader protein (1)
- epitaxy (1)
- epithelial-cells (1)
- escherichia coli (1)
- extracellular enzymes (1)
- fMRI (1)
- fear memory (1)
- fluorescence-activated cell sorting (1)
- fluorescent probe (1)
- fluorine (1)
- foamyviruses (1)
- fracture model (1)
- freezing (1)
- gastric cancer (1)
- gastrointestinal infections (1)
- gastrointestinal tract (1)
- gel electrophoresis (1)
- gene expression (1)
- gene expression profiling (1)
- gene flow (1)
- gene-cluster (1)
- gene-expression (1)
- gene-therapy (1)
- genes (1)
- genetic causes of cancer (1)
- genetic risk factor (1)
- genetic transcription (1)
- genetically modified crops (1)
- genetically modified plants (1)
- genome (1)
- genomic databases (1)
- german people (1)
- gis (1)
- glomerulus (1)
- gonads (1)
- guidance (1)
- gynogenesis (1)
- haploinsufficiency (1)
- haplotypes (1)
- helical tomotherapy (1)
- helicobacter pylori infection (1)
- hemocompatibility (1)
- homologous recombination (1)
- honey bees (1)
- honeybee (1)
- host (organism) (1)
- human (1)
- hybridomas (1)
- hyperalgesia (1)
- hypersensitive response (1)
- immunohistochemistry techniques (1)
- immunoprecipitation (1)
- in vivo imaging (1)
- in-vivo (1)
- indans (1)
- infarction (1)
- infection (1)
- inflammation (1)
- innate immunity (1)
- insect pests (1)
- insects (1)
- insulin (1)
- insulin-like growth factor 1 (IGF1) (1)
- integration (1)
- interleukins (1)
- interspecific comparison (1)
- introgression (1)
- inundation (1)
- iron (1)
- isoform (1)
- joint action (1)
- keratosis (1)
- kinase (1)
- larvae (1)
- levodopa (1)
- libraries (1)
- limitations (1)
- lipid imaging (1)
- low carbohydrate diet (1)
- lumps (1)
- lung-cancer (1)
- lymph nodes (1)
- lymphomas (1)
- macroglomerulus (1)
- macrophages (1)
- magnetic resonance imaging (1)
- magnetometry (1)
- maize (1)
- management (1)
- map (1)
- maps (1)
- masked priming (1)
- mass spectrometry (1)
- mastocytosis (1)
- measles virus (1)
- mechanisms (1)
- medicin (1)
- megavoltage computed-tomography (1)
- melanogaster (1)
- melanoma (1)
- meningococcal disease (1)
- messanger RNA (1)
- messenger RNA (1)
- metabolomics (1)
- metacarpal (1)
- methods (1)
- mice (1)
- microdissection (1)
- microsatellites (1)
- migraineur (1)
- moclobemide (1)
- modulation of virus replication (1)
- monoamine oxidase (1)
- monoamine oxidase inhibitors (1)
- mouse (1)
- mtDNA (1)
- mushroom body (1)
- mutation databases (1)
- nanoparticles (1)
- nanotechnology (1)
- neisseria meningitidis (1)
- nephroblastoma (1)
- neuroimaging (1)
- neurology (1)
- neuropil (1)
- nitric-oxide (1)
- no (1)
- nociceptor sensitization (1)
- northern blotting (1)
- nuclear envelope (1)
- obstructive pulmonary-disease (1)
- olfaction (1)
- olfactory glomeruli (1)
- olfactory information (1)
- oncolytic virotherapy (1)
- oncolytic virus (1)
- oocytes (1)
- opioids (1)
- optimisation (1)
- optimization (1)
- organization (1)
- osteotomy (1)
- palliative care (1)
- panel (1)
- paternal introgression (1)
- pathogenetic organism (1)
- pathogenicity (1)
- pathway (1)
- pediatrics (1)
- permaforst mountain (1)
- permafrost (1)
- phenelzine (1)
- pilot study (1)
- plants (1)
- plasticity (1)
- plate fixation (1)
- platelet-adhesion (1)
- pneumolysin (1)
- pol messenger-rna (1)
- pollen (1)
- poly(ethylene glycol) (1)
- population genetics (1)
- pore formation (1)
- prefrontal cortex (1)
- presynaptic inhibition (1)
- primary tumor cell culture (1)
- prognosis (1)
- prognostic biomarkers (1)
- proinflammatory cytokine (1)
- prostate-cancer (1)
- protein adsorption (1)
- quality of life (1)
- questionnaire (1)
- radar (1)
- radiotherapy (1)
- ralstonia solanacearum (1)
- rasagiline (1)
- reaction time (1)
- real-life interaction (1)
- receptor (1)
- recombinant proteins (1)
- regulatory RNA (1)
- reporter (1)
- reputation (1)
- requirements management (1)
- research errors (1)
- retinoic acid (1)
- retroviral vectors (1)
- reveals (1)
- reverse-transcriptase (1)
- review (1)
- rod degeneration (1)
- salivary gland lymph node (1)
- sar (1)
- satellite data (1)
- sauropod dinosaurs (1)
- scholarly publishing (1)
- sciatic nerves (1)
- scientific publishing (1)
- screening tools (1)
- secretion systems (1)
- seed aging (1)
- seed quality (1)
- selegiline (1)
- self-assembled monolayers (1)
- sequence databases (1)
- sex ratio (1)
- silico model (1)
- silver staining (1)
- simulation (1)
- single-crystal X-ray study (1)
- skin neoplasms (1)
- skull (1)
- small RNA (1)
- social interaction (1)
- somatic mutations (1)
- space missions phases (1)
- spatial cuing (1)
- spatial representation (1)
- sperm (1)
- sphingomyelinase (1)
- spinal cord (1)
- spinal-cord-injury (1)
- spine radiosurgery (1)
- splicing defect (1)
- spontaneously hypersensitive-rats (1)
- streptomyces (1)
- subviral particle release (1)
- sucrose allocation (1)
- surface coating (1)
- surfaces (1)
- symptom control (1)
- telomeres (1)
- terminal gag domain (1)
- testes (1)
- therapy (1)
- thyroid cancer (1)
- transcription factor function (1)
- transcription initiation site (1)
- tranylcypromine (1)
- treatment (1)
- tumor model (1)
- type III protein secretion system complex (1)
- type III secretion system pathways (1)
- unicellular cyanobacteria (1)
- untranslated regions (1)
- urine (1)
- variability analysis (1)
- varicella-zoster virus immunosuppression (1)
- version control (1)
- vertebral metastases (1)
- vertebral pneumaticity (1)
- virulence (1)
- wR factor = 0.069 (1)
- wikis (1)
- xanthomonas (1)
- xanthomonas campestris (1)
- zebrafish (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (42)
- Neurologische Klinik und Poliklinik (17)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (16)
- Institut für Molekulare Infektionsbiologie (14)
- Medizinische Klinik und Poliklinik I (14)
- Physikalisches Institut (13)
- Medizinische Klinik und Poliklinik II (9)
- Institut für Humangenetik (8)
- Institut für Psychologie (8)
- Institut für Virologie und Immunbiologie (8)
Sonstige beteiligte Institutionen
Immunoassays are routinely used as research tools to measure intracellular cAMP and cGMP concentrations. Ideally, this application requires antibodies with high sensitivity and specificity. The present work evaluates the cross-reactivity of commercially available cyclic nucleotide analogs with two non-radioactive and one radioactive cAMP and cGMP immunoassay. Most of the tested cyclic nucleotide analogs showed low degree competition with the antibodies; however, with Rp-cAMPS, 8-Br-cGMP and 8-pCPT-cGMP, a strong cross-reactivity with the corresponding cAMP and cGMP, respectively, immunoassays was observed. The determined EIA-binding constants enabled the measurement of the intracellular cyclic nucleotide concentrations and revealed a time- and lipophilicity-dependent cell membrane permeability of the compounds in the range of 10–30% of the extracellular applied concentration, thus allowing a more accurate prediction of the intracellular analog levels in a given experiment.
In Vivo Imaging of Stepwise Vessel Occlusion in Cerebral Photothrombosis of Mice by \(^{19}\)F MRI
(2011)
Background
\(^{19}\)F magnetic resonance imaging (MRI) was recently introduced as a promising technique for in vivo cell tracking. In the present study we compared \(^{19}\)F MRI with iron-enhanced MRI in mice with photothrombosis (PT) at 7 Tesla. PT represents a model of focal cerebral ischemia exhibiting acute vessel occlusion and delayed neuroinflammation.
Methods/Principal Findings
Perfluorocarbons (PFC) or superparamagnetic iron oxide particles (SPIO) were injected intravenously at different time points after photothrombotic infarction. While administration of PFC directly after PT induction led to a strong \(^{19}\)F signal throughout the entire lesion, two hours delayed application resulted in a rim-like \(^{19}\)F signal at the outer edge of the lesion. These findings closely resembled the distribution of signal loss on T2-weighted MRI seen after SPIO injection reflecting intravascular accumulation of iron particles trapped in vessel thrombi as confirmed histologically. By sequential administration of two chemically shifted PFC compounds 0 and 2 hours after illumination the different spatial distribution of the \(^{19}\)F markers (infarct core/rim) could be visualized in the same animal. When PFC were applied at day 6 the fluorine marker was only detected after long acquisition times ex vivo. SPIO-enhanced MRI showed slight signal loss in vivo which was much more prominent ex vivo indicative for neuroinflammation at this late lesion stage.
Conclusion
Our study shows that vessel occlusion can be followed in vivo by \(^{19}\)F and SPIO-enhanced high-field MRI while in vivo imaging of neuroinflammation remains challenging. The timing of contrast agent application was the major determinant of the underlying processes depicted by both imaging techniques. Importantly, sequential application of different PFC compounds allowed depiction of ongoing vessel occlusion from the core to the margin of the ischemic lesions in a single MRI measurement.
Background:
The etiology of secondary cancer in childhood cancer survivors is largely unclear. Exposure of normal somatic cells to radiation and/or chemotherapy can damage DNA and if not all DNA lesions are properly fixed, the mis-repair may lead to pathological consequences. It is plausible to assume that genetic differences, i.e. in the pathways responsible for cell cycle control and DNA repair, play a critical role in the development of secondary cancer.
Methodology/Findings:
To identify factors that may influence the susceptibility for second cancer formation, we recruited 20 individuals who survived a childhood malignancy and then developed a second cancer as well as 20 carefully matched control individuals with childhood malignancy but without a second cancer. By antibody microarrays, we screened primary fibroblasts of matched patients for differences in the amount of representative DNA repair-associated proteins. We found constitutively decreased levels of RAD9A and several other DNA repair proteins in two-cancer patients, compared to one-cancer patients. The RAD9A protein level increased in response to DNA damage, however to a lesser extent in the two-cancer patients. Quantification of mRNA expression by real-time RT PCR revealed lower RAD9A mRNA levels in both untreated and 1 Gy gamma-irradiated cells of two-cancer patients.
Conclusions/Significance:
Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.
Background: The etiology of secondary cancer in childhood cancer survivors is largely unclear. Exposure of normal somatic cells to radiation and/or chemotherapy can damage DNA and if not all DNA lesions are properly fixed, the mis-repair may lead to pathological consequences. It is plausible to assume that genetic differences, i.e. in the pathways responsible for cell cycle control and DNA repair, play a critical role in the development of secondary cancer. Methodology/Findings: To identify factors that may influence the susceptibility for second cancer formation, we recruited 20 individuals who survived a childhood malignancy and then developed a second cancer as well as 20 carefully matched control individuals with childhood malignancy but without a second cancer. By antibody microarrays, we screened primary fibroblasts of matched patients for differences in the amount of representative DNA repair-associated proteins. We found constitutively decreased levels of RAD9A and several other DNA repair proteins in two-cancer patients, compared to onecancer patients. The RAD9A protein level increased in response to DNA damage, however to a lesser extent in the twocancer patients. Quantification of mRNA expression by real-time RT PCR revealed lower RAD9A mRNA levels in both untreated and 1 Gy c-irradiated cells of two-cancer patients. Conclusions/Significance: Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.
Background: In principle, the elimination of malignancies by oncolytic virotherapy could proceed by different mechanisms - e.g. tumor cell specific oncolysis, destruction of the tumor vasculature or an anti-tumoral immunological response. In this study, we analyzed the contribution of these factors to elucidate the responsible mechanism for regression of human breast tumor xenografts upon colonization with an attenuated vaccinia virus (VACV). Methods: Breast tumor xenografts were analyzed 6 weeks post VACV infection (p.i.; regression phase) by immunohistochemistry and mouse-specific expression arrays. Viral-mediated oncolysis was determined by tumor growth analysis combined with microscopic studies of intratumoral virus distribution. The tumor vasculature was morphologically characterized by diameter and density measurements and vessel functionality was analyzed by lectin perfusion and extravasation studies. Immunological aspects of viral-mediated tumor regression were studied in either immune-deficient mouse strains (T-, B-, NK-cell-deficient) or upon cyclophosphamide-induced immunosuppression (MHCII+-cell depletion) in nude mice. Results: Late stage VACV-infected breast tumors showed extensive necrosis, which was highly specific to cancer cells. The tumor vasculature in infected tumor areas remained functional and the endothelial cells were not infected. However, viral colonization triggers hyperpermeability and dilatation of the tumor vessels, which resembled the activated endothelium in wounded tissue. Moreover, we demonstrated an increased expression of genes involved in leukocyte-endothelial cell interaction in VACV-infected tumors, which orchestrate perivascular inflammatory cell infiltration. The immunohistochemical analysis of infected tumors displayed intense infiltration of MHCII-positive cells and colocalization of tumor vessels with MHCII+/CD31+ vascular leukocytes. However, GI-101A tumor growth analysis upon VACV-infection in either immunosuppressed nude mice (MHCII+-cell depleted) or in immune-deficient mouse strains (T-, B-, NK-cell-deficient) revealed that neither MHCII-positive immune cells nor T-, B-, or NK cells contributed significantly to VACV-mediated tumor regression. In contrast, tumors of immunosuppressed mice showed enhanced viral spreading and tumor necrosis. Conclusions: Taken together, these results indicate that VACV-mediated oncolysis is the primary mechanism of tumor shrinkage in the late regression phase. Neither the destruction of the tumor vasculature nor the massive VACV-mediated intratumoral inflammation was a prerequisite for tumor regression. We propose that approaches to enhance viral replication and spread within the tumor microenvironment should improve therapeutical outcome.
In the model plant Arabidopsis thaliana, more than 2000 genes are estimated to encode transcription factors (TFs), which clearly emphasizes the importance of transcriptional control. Although genomic approaches have generated large TF open reading frame (ORF) collections, only a limited number of these genes is functionally characterized, yet. This review evaluates strategies and methods to identify TF functions. In particular, we focus on two recently developed TF screening platforms, which make use of publically available GATEWAY®-compatible ORF collections. (1) The Arabidopsis thaliana TF ORF over-Expression (AtTORF-Ex) library provides pooled collections of transgenic lines over-expressing HA-tagged TF genes, which are suited for screening approaches to define TF functions in stress defense and development. (2) A high-throughput microtiter plate based protoplast trans activation (PTA) system has been established to screen for TFs which are regulating a given promoter:Luciferase construct in planta.
Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro
(2011)
Background: Wilms tumor (WT) is one of the most common malignancies in childhood. With current therapy protocols up to 90% of patients can be cured, but there is still a need to improve therapy for patients with aggressive WT and to reduce treatment intensity where possible. Prior data suggested a deregulation of the retinoic acid (RA) signaling pathway in high-risk WT, but its mode of action remained unclear. Results: The association of retinoid signaling and clinical parameters could be validated in a large independent tumor set, but its relevance in primary nephrectomy tumors from very young children may be different. Reduced RA pathway activity and MYCN overexpression were found in high risk tumors as opposed to tumors with low/ intermediate risk, suggesting a beneficial impact of RA especially on advanced WT. To search for possible modes of action of retinoids as novel therapeutic options, primary tumor cell cultures were treated in vitro with all-trans-RA (ATRA), 9cis-RA, fenretinide and combinations of retinoids and a histone deacetylase (HDAC) inhibitor. Genes deregulated in high risk tumors showed opposite changes upon treatment suggesting a positive effect of retinoids. 6/7 primary cultures tested reduced proliferation, irrespective of prior RA signaling levels. The only variant culture was derived from mesoblastic nephroma, a distinct childhood kidney neoplasm. Retinoid/HDAC inhibitor combinations provided no synergistic effect. ATRA and 9cis-RA induced morphological changes suggestive of differentiation, while fenretinide induced apoptosis in several cultures tested. Microarray analysis of ATRA treated WT cells revealed differential expression of many genes involved in extracellular matrix formation and osteogenic, neuronal or muscle differentiation. The effects documented appear to be reversible upon drug withdrawal, however. Conclusions: Altered retinoic acid signaling has been validated especially in high risk Wilms tumors. In vitro testing of primary tumor cultures provided clear evidence of a potential utility of retinoids in Wilms tumor treatment based on the analysis of gene expression, proliferation, differentiation and apoptosis.
Background:
Single drug use has not achieved satisfactory results in the treatment of prostate cancer, despite application of increasingly widespread targeted therapeutics. In the present study, the combined impact of the mammalian target of rapamycin (mTOR)-inhibitor RAD001, the dual EGFr and VGEFr tyrosine kinase inhibitor AEE788 and the histone deacetylase (HDAC)-inhibitor valproic acid (VPA) on prostate cancer growth and adhesion in vitro was investigated.
Methods:
PC-3, DU-145 and LNCaP cells were treated with RAD001, AEE788 or VPA or with a RAD-AEE-VPA combination. Tumor cell growth, cell cycle progression and cell cycle regulating proteins were then investigated by MTT-assay, flow cytometry and western blotting, respectively. Furthermore, tumor cell adhesion to vascular endothelium or to immobilized extracellular matrix proteins as well as migratory properties of the cells was evaluated, and integrin alpha and beta subtypes were analyzed. Finally, effects of drug treatment on cell signaling pathways were determined.
Results:
All drugs, separately applied, reduced tumor cell adhesion, migration and growth. A much stronger anticancer effect was evoked by the triple drug combination. Particularly, cdk1, 2 and 4 and cyclin B were reduced, whereas p27 was elevated. In addition, simultaneous application of RAD001, AEE788 and VPA altered the membranous, cytoplasmic and gene expression pattern of various integrin alpha and beta subtypes, reduced integrin-linked kinase (ILK) and deactivated focal adhesion kinase (FAK). Signaling analysis revealed that EGFr and the downstream target Akt, as well as p70S6k was distinctly modified in the presence of the drug combination.
Conclusions:
Simultaneous targeting of several key proteins in prostate cancer cells provides an advantage over targeting a single pathway. Since strong anti-tumor properties became evident with respect to cell growth and adhesion dynamics, the triple drug combination might provide progress in the treatment of advanced prostate cancer.
Background: Hemostasis is a critical and active function of the blood mediated by platelets. Therefore, the prevention of pathological platelet aggregation is of great importance as well as of pharmaceutical and medical interest. Endogenous platelet inhibition is predominantly based on cyclic nucleotides (cAMP, cGMP) elevation and subsequent cyclic nucleotide-dependent protein kinase (PKA, PKG) activation. In turn, platelet phosphodiesterases (PDEs) and protein phosphatases counterbalance their activity. This main inhibitory pathway in human platelets is crucial for countervailing unwanted platelet activation. Consequently, the regulators of cyclic nucleotide signaling are of particular interest to pharmacology and therapeutics of atherothrombosis. Modeling of pharmacodynamics allows understanding this intricate signaling and supports the precise description of these pivotal targets for pharmacological modulation. Results: We modeled dynamically concentration-dependent responses of pathway effectors (inhibitors, activators, drug combinations) to cyclic nucleotide signaling as well as to downstream signaling events and verified resulting model predictions by experimental data. Experiments with various cAMP affecting compounds including antiplatelet drugs and their combinations revealed a high fidelity, fine-tuned cAMP signaling in platelets without crosstalk to the cGMP pathway. The model and the data provide evidence for two independent feedback loops: PKA, which is activated by elevated cAMP levels in the platelet, subsequently inhibits adenylyl cyclase (AC) but as well activates PDE3. By multi-experiment fitting, we established a comprehensive dynamic model with one predictive, optimized and validated set of parameters. Different pharmacological conditions (inhibition, activation, drug combinations, permanent and transient perturbations) are successfully tested and simulated, including statistical validation and sensitivity analysis. Downstream cyclic nucleotide signaling events target different phosphorylation sites for cAMP- and cGMP-dependent protein kinases (PKA, PKG) in the vasodilator-stimulated phosphoprotein (VASP). VASP phosphorylation as well as cAMP levels resulting from different drug strengths and combined stimulants were quantitatively modeled. These predictions were again experimentally validated. High sensitivity of the signaling pathway at low concentrations is involved in a fine-tuned balance as well as stable activation of this inhibitory cyclic nucleotide pathway. Conclusions: On the basis of experimental data, literature mining and database screening we established a dynamic in silico model of cyclic nucleotide signaling and probed its signaling sensitivity. Thoroughly validated, it successfully predicts drug combination effects on platelet function, including synergism, antagonism and regulatory loops.
Background:
Early-onset obsessive-compulsive disorder (OCD) is one of the more common mental illnesses of children and adolescents, with prevalence of 1% to 3%. Its manifestations often lead to severe impairment and to conflict in the family. In this review, we summarize the manifestations, comorbidity, pathophysiology, and course of this disease as well as current modes of diagnosis and treatment.
Methods:
We selectively review the relevant literature and the German-language guidelines for the diagnosis and treatment of mental illnesses in children and adolescents.
Results:
Obsessive-compulsive manifestations are of many types and cause severe impairment. Comorbid mental disturbances are present in as many as 70% of patients. The disease takes a chronic course in more than 40% of patients. Cognitive behavioral therapy is the treatment of first choice, followed by combination pharmacotherapy including selective serotonin reuptake inhibitors (SSRI) and then by SSRI alone.
Conclusion:
OCD often begins in childhood or adolescence. There are empirically based neurobiological and cognitive-behavioral models of its pathophysiology. Multiaxial diagnostic evaluation permits early diagnosis. Behavioral therapy and medications are highly effective treatments, but the disorder nonetheless takes a chronic course in a large percentage of patients.